Literature DB >> 12674211

Phenotypic overlap between monocytes and vascular endothelial cells.

Alexander Schmeisser1, Christiane Graffy, Werner G Daniel, Ruth H Strasser.   

Abstract

During embryonic development, endothelial cells (ECs) develop organ specific properties. ECs express specific markers, which are helpful in identifying these cells in vivo and in culture. Interestingly, most of the supposed specific endothelial markers are present on both ECs and hematopoietic precursors or mature blood cells, which correspond to the idea of a common embryonic precursor. Monocytes/makrophages and monocyte-derived dendritic cells, as more differentiated hematopoietic cell populations, show a wide phenotypic overlap with particularly hepatic sinusoidal, and microvascular endothelial cells within inflamed tissue, such as neovascularizised complicated atherosclerotic plaques. Furthermore, under local angiogenic growth conditions monocytes or monocyte precursors or immature dendritic cells may differentiate into endothelial like cells. First evidence suggests an endothelium-independent revascularization potential carried by monocyte-derived macrophages. These macrophages have been shown to form tunnel-like structures in ischemic regions. Future studies have to address the question, whether monocyte-/dendritic cell-derived endothelial like cells can develop a similar functional behaviour in vasoregulation, coagulation and fibrinolysis, as described for vascular endothelial cells, and thus may contribute to neoangiogenesis by a direct vessel-forming role.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12674211     DOI: 10.1007/978-1-4615-0169-5_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells.

Authors:  Sarah J Ohle; Asha Anandaiah; Attila J Fabian; Alan Fine; Darrell N Kotton
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-09       Impact factor: 6.914

Review 2.  Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis.

Authors:  Gregor Prindull
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Alteration in the gene expression pattern of primary monocytes after adhesion to endothelial cells.

Authors:  Sybill Thomas-Ecker; Antje Lindecke; Wolfgang Hatzmann; Christian Kaltschmidt; Kurt S Zänker; Thomas Dittmar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

Review 4.  Endothelial progenitor cells: quo vadis?

Authors:  Matthew R Richardson; Mervin C Yoder
Journal:  J Mol Cell Cardiol       Date:  2010-07-29       Impact factor: 5.000

Review 5.  Isolating and defining cells to engineer human blood vessels.

Authors:  P J Critser; S L Voytik-Harbin; M C Yoder
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 6.  Circulating and tissue resident endothelial progenitor cells.

Authors:  David P Basile; Mervin C Yoder
Journal:  J Cell Physiol       Date:  2014-01       Impact factor: 6.384

7.  Chitotriosidase Expression during Monocyte-Derived Dendritic Cells Differentiation and Maturation.

Authors:  Michelino Di Rosa; Daniele Tibullo; Daniela Cambria; Gisella Distefano; Salvatore Saccone; Francesco Di Raimondo; Lucia Malaguarnera
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

Review 8.  Human endothelial progenitor cells.

Authors:  Mervin C Yoder
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 9.  Assessing identity, phenotype, and fate of endothelial progenitor cells.

Authors:  Karen K Hirschi; David A Ingram; Mervin C Yoder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

Review 10.  The chemokine system in arteriogenesis and hind limb ischemia.

Authors:  Paula K Shireman
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.